-
UK PM dismisses Russian threats as Ukraine allies gather in Kyiv
-
India declare on 503-9 after Jurel hundred
-
Attacks on Red Cross in DR Congo making Ebola fight 'harder'
-
Kremlin says UK preventing peace by giving missile info to Ukraine
-
Oil falls ahead of US plan for economic war on Iran
-
Springboks change half-backs for second All Blacks Test
-
Millions of Teslas recalled in China over door handle safety
-
Jurel hits 95 not out as India reach 475-8 at tea in Sri Lanka Test
-
IUX Launches New Education Webinar Series to Support Traders’ Financial Literacy
-
Ingebrigtsen buoyed by fourth in Diamond League comeback
-
Dutch say won't participate in 'no longer' neutral Eurovision
-
Kenyans get creative to join manga cosplay craze
-
Kenyan farmers turn to bugs as organic demand grows
-
Pant, Jurel half-centuries take India past 400 in Sri Lanka Test
-
'His feet are his pillars': Nepal para swimmer gives all for Asian glory
-
Migrants, rescue ships face threats, harassment at sea: aid group
-
New Zealand moves to ban social media for under-16s
-
UEFA's Ceferin tells Infantino to go, but 'not interested' in replacing him
-
Hyundai union back in wage talks after rare full-day strike
-
Oil falls as Trump pledges economic war on Iran
-
Shein grapples with EU backlash, but clients keep coming
-
Yamashita marches to nine-shot win in LPGA Canadian Women's Open
-
Key facts about Chinese-founded fast-fashion giant Shein
-
Gauff powers past Pegula to win US Open warm-up in Cincinnati
-
Shein to make market debut in Hong Kong in September
-
Japan's Olympic figure skating heroes to wed
-
Fils tops Tiafoe to claim first ATP Masters title in Cincinnati
-
Cummins eyes ODI return ahead of 'big' South Africa Test series
-
Gauff powers past Pegula to win Cincinnati WTA 1000 crown
-
RMTG's Cellgenic Division Launches Natural Killer (NK) Cell Product Line for International Markets
-
WyoTech Represented on the National Stage at the Great Race
-
Electrovaya Commences Factory Acceptance Testing of Cell Manufacturing Line for Jamestown Cell Manufacturing Facility
-
SK Tes Publishes 2025 Sustainability Report: Resilience in the Circular Economy
-
Ferrari Purosangue Now Available to Rent in Miami
-
Electric Metals Launches Multi-Workstream Program to Strengthen Economics of the US$1.39 Billion North Star Manganese Project
-
Quorum Technologies Debuts Bioz Badges to Connect Researchers with Product Evidence
-
Oleria and Happiest Minds Partner to Accelerate Modern Identity Governance for AI-First Enterprises
-
Sinopec Achieves Solid Operating Results in the First Half of 2026
-
Global Education Communities Corp. Provides Update on the Atmosphere Project
-
Galway Metals Continues to Demonstrate Broad Gold Mineralization at Southwest Deposit; 2.0 g/t Gold Over 68.0 Metres
-
Start the New Year Right: Practical Life Resolutions
-
Cyber Enviro-Tech Announces Definitive Agreement With Air Power USA to Advance Global Clean Energy Commercialization As $45M Funding MOU Emerges Pending Consolidation of the Companies
-
Zide Opens Public Beta of Its Native AI Development Workspace - Code, Git, Issues, and CI in One App
-
ZTEST Electronics Inc. Announces the Grant of Stock Options to CEO and Directors
-
Black Book Announces 2026 Converged Clinical AI Platform Category and Market Assessment
-
Gold Terra Announces Sonic Drill Program to Evaluate Gold Content in Con Mine Historical Tailings, Yellowknife, NWT and Stock Options Grant
-
Amarc Announces CAD$20 Million Private Placement Financing
-
India police used excessive force during protests: Amnesty
-
Ukraine backers gather as war escalates, air defence runs low
-
Rookie La Sasso wins LIV season-ender as tour's future in doubt
Vanta Announces Closing of Second Tranche of Private Placement for Aggregate Gross Proceeds of $1 Million
VANCOUVER, BC / ACCESS Newswire / May 6, 2026 / Vanta Holdings Inc. (CSE:VNTA)(OTC:VNTXF)(FSE:7BC, WKN:A4205J) ("Vanta" or the "Company"), a consumer health sciences company and parent of the Vanta premium hydration and longevity brand, announces that, further to its news release dated May 5, 2026, the Company has closed the second tranche (the "Second Tranche") of its previously announced non-brokered private placement (the "Private Placement").
Under the Second Tranche, the Company issued 615,000 units (each, a "Unit") at a price of $1.00 per Unit, for aggregate gross proceeds of $615,000. Each Unit consists of one common share in the capital of the Company (each, a "Share") and one transferable common share purchase warrant (each, a "Warrant"). Each Warrant entitles the holder to acquire one additional Share (each, a "Warrant Share") at an exercise price of $1.25 per Warrant Share until May 6, 2028.
The closing of the Second Tranche, together with the previously announced closing of the first tranche on May 5, 2026, brings the aggregate gross proceeds of the Private Placement to $1,000,000.
The net proceeds of the Private Placement are intended to be allocated towards the payment of outstanding and future payables and indebtedness, including amounts owing to related parties, corporate awareness, product inventory, and general working capital purposes.
All securities issued under the Second Tranche of the Private Placement are subject to a statutory hold period expiring on September 7, 2026, in accordance with applicable securities laws.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy securities in the United States, nor shall there be any sale of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful. The securities being offered have not been, nor will they be, registered under the U.S. Securities Act of 1933, as amended (the "1933 Act"), or under any U.S. state securities laws, and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the 1933 Act and applicable state securities laws.
About Vanta Holdings Inc.
Vanta Holdings Inc. (CSE:VNTA)(OTC:VNTXF)(FSE:7BC; WKN:A4205J) is a consumer health sciences company and the parent of the Vanta premium hydration and longevity brand. The Company develops, manufactures, and distributes functionally formulated beverages and nutraceutical products designed to support cellular function, mitochondrial energy, and metabolic performance. Through its Vanta brand and select private-label partnerships, the Company formulates alkaline and mineral-enriched ready-to-drink beverages, including its flagship Blackwater, alongside performance-oriented nutraceutical supplements featuring bioactive compounds and trace mineral complexes. Vanta's strategy focuses on building premium, science-driven functional hydration and nutraceutical brands supported by scalable manufacturing and distribution capabilities. The Company operates an integrated platform spanning product formulation, in-house research and development, manufacturing, brand development, and multi-channel distribution across domestic and international markets. This includes ownership of a natural alkaline spring water aquifer and a 40,000-square-foot, Health Canada and HACCP-certified manufacturing facility in the mountains of British Columbia. Vanta distributes its products through a diversified approach, including retail, direct-to-consumer e-commerce, and strategic distribution partnerships.
On behalf of the Board of Directors:
Martino Ciambrelli, Director
[email protected]
604-569-1414
Disclaimer for Forward-Looking Information
This news release contains forward-looking statements within the meaning of applicable securities laws. Forward-looking statements in this release include, but are not limited to, statements relating to: the intended use of proceeds of the Private Placement. Forward-looking information is based on management's current expectations, estimates, assumptions, and projections as of the date of this news release. Such information is subject to a number of known and unknown risks, uncertainties, and other factors that may cause actual results, performance, or achievements to differ materially from those expressed or implied by such forward-looking information. These risks and uncertainties include, without limitation: the Company's ability to utilize the proceeds of the Private Placement as intended; and general economic, financial, and capital market conditions. Forward-looking information is not a guarantee of future performance and reflects management's expectations only as of the date hereof. There can be no assurance that the Company will achieve its intended use of proceeds described herein. Except as required by applicable securities laws, the Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, future events, or otherwise. Readers are cautioned not to place undue reliance on forward-looking information.
SOURCE: Vanta Holdings Inc.
View the original press release on ACCESS Newswire
A.Clark--AT